Voyager Therapeutics’ Potential Gene Therapy Program for FA Moving Toward Pre-Clinical Stage – Friedreich’s Ataxia News
Friedreich’s Ataxia News |
Voyager Therapeutics' Potential Gene Therapy Program for FA Moving Toward Pre-Clinical Stage
Friedreich’s Ataxia News A previous study showed that gene therapy strategies can have the potential to overcome the frataxin (FXN) deficiency found in Friedreich's ataxia. Based on advanced viral vectors gene delivery technology, Voyager researchers were able to promote the … |
